Clinical Trials Browser

Phase 2 × NSCLC × Bevacizumab × Clear all

NCT07134413 2025-08-21

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

Phase 2 Not yet recruiting

NSCLC